Skip to main content

Senile Osteoporosis as a Geriatric Syndrome

  • Chapter
Osteoporosis in Older Persons

With the rise in the aging population, osteoporosis has become a major health burden. From 50 years of age onward, 4 in 10 women will have a hip, vertebral, or forearm fracture. And in the years to come, they are more likely to die from complications as a consequence of fracture rather than from breast cancer. Although osteoporosis is viewed as a disease occurring in post-menopausal women, men account for 30%of hip fractures worldwide (1). More importantly, osteoporosis causes a greater health burden in older people. Billions of dollars are spent each year in the US on acute and long-term care required for people who sustain osteoporosisrelated fractures (2). Globally, osteoporotic fractures caused an estimated 5.8 million disability adjusted life years in the year 2000 (3). This fi gure is expected to increase worldwide as the population ages. Fractures, as a result of osteoporosis, consume a signifi cant proportion of healthcare resources. Recently, the annual cost of all osteoporotic fractures in the US has been estimated to be $20 billion (2). In 1995, more than 400,000 hospitalizations, 3.4 million outpatient visits, and 179,000 nursing home admissions were a direct consequence of osteoporotic fractures (1). Hip fractures have the highest morbidity and mortality. Almost all of the hip fractures occur after a fall; 80% occur amongst women and 90% occur in people over the age of 50 (2). People with hip fractures have 12–39% higher mortality in the immediate following year compared to the same age population; 13–50% of survivors are not able to walk after the event and 12–20% of the survivors need nursing home placement (2). Vertebral fractures are the most common osteoporotic fractures. Many are not recognized clinically. Whether recognized clinically or not, they cause pain, height loss, deformity, and increased risk for further fractures (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Colon-Emeric CS, Saag KG. Osteoporotic fractures in older adults. Best Prac Res Clin Rheumatol 2006;20:695–706.

    Article  Google Scholar 

  2. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010–2018.

    Article  CAS  PubMed  Google Scholar 

  3. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 2000;11:551– 552.

    Article  Google Scholar 

  4. Lyles KW, Gold DT, Shipp KM, et al. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 1993;94: 595–601.

    Article  CAS  PubMed  Google Scholar 

  5. Chan GK, Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002;48:62–71.

    Article  PubMed  Google Scholar 

  6. Tidermark J, Ponzer S, Carlsson P, et al. Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clin Nutr 2004;23:587–596.

    Article  CAS  PubMed  Google Scholar 

  7. Sambrook PN, Cameron ID, Chen JS, et al. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int 2007;18)5):603–610.

    Article  CAS  PubMed  Google Scholar 

  8. Court-Brown CM, Caesar B. Epidemiology of adult fractures: a review. Injury 2006;37:691–697.

    Article  PubMed  Google Scholar 

  9. Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997;45:281–287.

    CAS  PubMed  Google Scholar 

  10. Cooper C, Campion G, Melton LJ. Hip-fractures in the elderly—a worldwide projection. Osteoporos Int 1992;2:285–289.

    Article  CAS  PubMed  Google Scholar 

  11. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7: 407–413.

    Article  CAS  PubMed  Google Scholar 

  12. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005;353:595–603.

    Article  CAS  PubMed  Google Scholar 

  13. Poole KE, Compston JE. Osteoporosis and its management. BMJ 2006;333:1251–1256.

    Article  CAS  PubMed  Google Scholar 

  14. Heffernan MP, Saag KG, Robinson JK, et al. Prevention of osteoporosis associated with chronic glucocorticoid therapy. JAMA 2006;295:1300– 1303.

    Article  CAS  PubMed  Google Scholar 

  15. No authors listed. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003;921:1–164.

    Google Scholar 

  16. Prestwood KM, Duque G. Osteoporosis. In: Textbook of principles of geriatric medicine and gerontology, 5th edition. Hazzard (ed.) New York: McGraw Hill, 2003, 973–986.

    Google Scholar 

  17. Kenny AM, Prestwood KM, Marcello KM, et al. Determinants of bone density in healthy older men with low testosterone levels. J Gerontol A Biol Sci Med Sci 2000;55:M492–M497.

    CAS  PubMed  Google Scholar 

  18. Mundy GR, Elefteriou F. Boning up on ephrin signaling. Cell 2006;126:441–443.

    Article  CAS  PubMed  Google Scholar 

  19. Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 2000;27:177–184.

    Article  CAS  PubMed  Google Scholar 

  20. Delmas PD, van de Langerijt L, Watts NB, et al. IMPACT Study Group. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 2005;20:557–563.

    Article  PubMed  Google Scholar 

  21. Black DM, Steinbuch M, Palermo L, et al. An ass essment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001;12: 519–528.

    Article  CAS  PubMed  Google Scholar 

  22. De Laet CE, van Hout BA, Burger H, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 1997;315:221–225.

    PubMed  Google Scholar 

  23. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001;49:664–672.

    Google Scholar 

  24. Hillier TA, Stone KL, Bauer DC, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med 2007;167:155–160.

    Article  PubMed  Google Scholar 

  25. Pieper CF, Colon-Emeric CS, Caminis J, et al. Distribution and correlates of serum 25-hydroxyvita-min D levels in a sample of hip fracture patients. Am J Geriatr Pharmacother [In press].

    Google Scholar 

  26. Heaney RP, Dowell MS, Hale CA, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamn D. J Amer Coll Nutr 2003;22:142–146.

    CAS  Google Scholar 

  27. Gallagher JC, Rapuri PB, Smith LM. An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab 2007;92:51–58.

    Article  CAS  PubMed  Google Scholar 

  28. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.

    Article  CAS  PubMed  Google Scholar 

  29. Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234–239.

    Article  PubMed  Google Scholar 

  30. Stone LM, Lyles KW. Generations—chronic conditions in later life. Journal of the American Society on Aging. Osteoporos Int 2006;30(3):65–70.

    Google Scholar 

  31. Sjosten NM, Salonoja M, Piirtola M, et al. A multi-factorial fall prevention programme in home-dwelling elderly people: a randomized-controlled trial. Am J Public Health 2007;12:308–318.

    Google Scholar 

  32. Rubin C, Recker R, Cullen D, et al. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res 2004;19:343–351.

    Article  PubMed  Google Scholar 

  33. Kita K, Hujino K, Nasu T, et al. A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease. Osteoporos Int 2007;18(5):611–619.

    Article  CAS  PubMed  Google Scholar 

  34. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434– 1441.

    Article  CAS  PubMed  Google Scholar 

  35. Seeman E, Vellas B, Benhamou C, et al. Strontium ranelate reduces the risk of vertebral and nonver-tebral fractures in women eighty years of age and older. J Bone Miner Res 2006;21:1113–1120.

    Article  CAS  PubMed  Google Scholar 

  36. Goltzman D. Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 2002;1:784–796.

    Article  CAS  PubMed  Google Scholar 

  37. Marcus R, Wang O, Satterwhite J, et al. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal with osteoporosis. J Bone Miner Res 2003;18:18–23.

    Article  CAS  PubMed  Google Scholar 

  38. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637– 1642.

    Article  CAS  PubMed  Google Scholar 

  39. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257–2264.

    Article  CAS  PubMed  Google Scholar 

  40. Gompel A, Barlow D, Rozenberg S, et al. EMAS Executive Committee. The EMAS 2006/2007 update on clinical recommendations on postmeno-pausal hormone therapy. Maturitas 2007;56:227– 229.

    Article  PubMed  Google Scholar 

  41. Qu Y, Wong M, Thiebaud D, et al. The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Curr Med Res Opin 2005;21:1955–1959.

    Article  CAS  PubMed  Google Scholar 

  42. Gaudio A, Morabito N. Pharmacological management of severe postmenopausal osteoporosis. Drugs Aging 2005;22:405–417.

    Article  CAS  PubMed  Google Scholar 

  43. Wehren LE, Hosking D, Hochberg MC. Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin 2004;20: 525–531.

    Article  PubMed  Google Scholar 

  44. Mulder JE, Kolatkar NS, LeBoff MS. Drug insight: existing and emerging therapies for osteoporosis. Nat Clin Pract Endocrinol Metab 2006;2:670–680.

    Article  CAS  PubMed  Google Scholar 

  45. Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for use of the antiresorptive agents in the old and oldest old. J Am Geriatr Soc 2004;52: 1832–1839.

    Article  PubMed  Google Scholar 

  46. Croom KF, Scott LJ. Intravenous ibandronate: in the treatment of osteoporosis. Drugs 2006;66: 1593–1601.

    Article  CAS  PubMed  Google Scholar 

  47. Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753–761.

    CAS  PubMed  Google Scholar 

  48. Bilezikian JP. Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 2006;355:2278–2281.

    Article  CAS  PubMed  Google Scholar 

  49. Stokkers PC, Deley M, Van Der Spek M, et al. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflam-matory bowel disease. Scand J Gastroenterol 2006; 41:200–204.

    Article  CAS  PubMed  Google Scholar 

  50. Colon-Emeric CS, Caminis J, Suh TT, et al. HORIZON Recurrent Fracture Trial. The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. Curr Med Res Opin 2004;20:903–910.

    Article  PubMed  Google Scholar 

  51. Cranney A, Papaioannou A, Zytaruk N, et al. Parathyroid hormone for the treatment of osteoporosis: a systematic review. CMAJ 2006;175:52–59.

    PubMed  Google Scholar 

  52. Shoback D. Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab 2007; 92:747–753.

    Article  CAS  PubMed  Google Scholar 

  53. Kanis JA, Black D, Cooper C, et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 2002;13:527–536.

    Article  CAS  PubMed  Google Scholar 

  54. Green AD, Colon-Emeric CS, Bastian L, et al. Does this woman have osteoporosis? JAMA 2004;292: 2890–2900.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Patel, R.H., Lyles, K.W. (2009). Senile Osteoporosis as a Geriatric Syndrome. In: Duque, G., Kiel, D.P. (eds) Osteoporosis in Older Persons. Springer, London. https://doi.org/10.1007/978-1-84628-697-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-697-1_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-515-8

  • Online ISBN: 978-1-84628-697-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics